Dr. Ioannis Vamvakaris is a researcher affiliated with the School of Medicine, Athens, Greece, specializing in oncology, immunology, and translational cancer research. With 42 publications, 680 citations, and an h-index of 12, he has established a strong academic presence in lung cancer studies, immunophenotyping, and biomarker-driven clinical research. His work includes contributions to multi-center clinical trials and high-impact studies in cancer immunotherapy, particularly focusing on tumor-infiltrating lymphocytes and molecular pathways influencing disease progression. Collaborating with an extensive international network of researchers, he integrates clinical and laboratory research to advance precision medicine. His research holds significant societal impact by improving cancer diagnosis, optimizing treatment strategies, and contributing to better patient outcomes, thereby supporting advancements in global oncology care and evidence-based clinical practice.
